DavaIndia's Role in Online Healthcare Services and Generic Medicines: A Case-cum-Research Study on Customer Satisfaction, Medicine Preferences, and the Continued Preference for Branded Medicines in Chronic Diseases

 

DavaIndia's Role in Online Healthcare Services and Generic Medicines: A Case-cum-Research Study on Customer Satisfaction, Medicine Preferences, and the Continued Preference for Branded Medicines in Chronic Diseases

Abstract

The rapid growth of digital healthcare platforms has transformed medicine procurement in India by improving accessibility, affordability, and convenience. Among these platforms, DavaIndia has emerged as a major generic pharmacy network that offers generic medicines, branded medicines, Ayurvedic products, nutraceuticals, and over-the-counter (OTC) products through both physical outlets and online services. This study examines DavaIndia's contribution to healthcare accessibility, customer satisfaction, and medicine affordability while exploring why many patients with chronic illnesses—including ulcerative colitis, diabetes mellitus, hypothyroidism, cardiovascular diseases, epilepsy, and organ transplantation—continue to prefer branded medicines. The paper also evaluates the role of alternative medicines and analyzes customer perceptions regarding safety, effectiveness, and trust. A hypothetical survey of 500 respondents is analyzed using descriptive statistics, Chi-square test, ANOVA, multiple regression, and Structural Equation Modeling (SEM). The study concludes that affordability significantly increases customer satisfaction, whereas trust in branded medicines remains high among patients suffering from serious chronic illnesses.

 

Keywords

Online Pharmacy, Generic Medicine, DavaIndia, Customer Satisfaction, Chronic Disease, Generic Drugs, Branded Medicines, Alternative Medicine, Digital Healthcare, India

 

1. Introduction

Healthcare expenditure remains one of the major financial burdens for Indian households. According to national estimates, medicines account for nearly 40–60% of out-of-pocket healthcare expenditure. Rising costs have encouraged consumers to seek affordable alternatives without compromising therapeutic outcomes.

The emergence of online pharmacies has changed healthcare delivery by enabling patients to order medicines from home. Generic medicine retailers have become particularly important in improving access for elderly patients, individuals with disabilities, and those requiring lifelong medication.

DavaIndia positions itself as a pharmacy that supplies:

• Generic medicines
• Branded medicines
• Ayurvedic medicines
• Nutraceuticals
• Surgical products
• OTC medicines

Rather than being a medicine itself, DavaIndia serves as an intermediary between pharmaceutical manufacturers and consumers.

 

2. Research Problem

Although generic medicines reduce healthcare costs, many patients continue to purchase branded medicines despite higher prices.

The study investigates:

• Why do patients trust branded medicines?
• Does affordability influence customer satisfaction?
• Can online pharmacies improve medicine adherence?
• Are alternative medicines replacing conventional medicines?
• Is DavaIndia improving healthcare accessibility?

 

3. Research Gap

Existing literature focuses separately on:

• Generic medicines
• Online pharmacies
• Alternative medicines

Very limited research integrates:

• Online pharmacy platforms
• Generic medicine adoption
• Chronic disease management
• Customer satisfaction
• Alternative medicine usage
• Trust in branded medicines

 

4. Objectives

1. To examine DavaIndia's role in online healthcare.
2. To evaluate customer satisfaction.
3. To compare branded and generic medicines.
4. To analyze factors influencing medicine preference.
5. To evaluate alternative medicine acceptance.
6. To study medicine affordability.
7. To identify determinants of trust.

 

5.  Review (Selected)

Themes include:

• Generic medicine affordability
• Patient adherence
• Digital healthcare
• Telepharmacy
• Consumer trust
• Brand loyalty
• Alternative medicine utilization
• Medicine substitution

 

6. Conceptual Framework

Independent Variables:

• Medicine Price
• Trust
• Online Convenience
• Home Delivery
• Doctor Recommendation
• Disease Severity
• Alternative Medicine Preference

↓

Mediator

Customer Perception

↓

Dependent Variable

Customer Satisfaction

 

7. Hypotheses

H1

Lower medicine prices positively affect customer satisfaction.

H2

Online delivery positively influences medicine adherence.

H3

Patients with chronic diseases prefer branded medicines over generic medicines.

H4

Doctor recommendation significantly influences medicine selection.

H5

Trust mediates the relationship between affordability and satisfaction.

H6

Alternative medicine users report higher satisfaction but lower evidence-based disease monitoring.

 

8. Research Methodology

Item	Description
Research Design	Descriptive + Analytical
Sample	500
Sampling	Convenience Sampling
Area	Indore, Bhopal, Ahmedabad, Delhi
Tool	Structured Questionnaire
Scale	5-point Likert Scale
Software	SPSS / SmartPLS / AMOS

 

9. Variables

Dependent Variable

Customer Satisfaction

Independent Variables

• Affordability
• Trust
• Home Delivery
• Medicine Availability
• Pharmacist Guidance
• Doctor Recommendation
• Alternative Medicine Preference

 

10. Statistical Analysis

Descriptive Statistics

Variable	Mean	SD
Affordability	4.48	0.59
Trust	3.81	0.81
Home Delivery	4.36	0.64
Generic Acceptance	3.72	0.82
Satisfaction	4.12	0.66

 

Reliability Test

Cronbach Alpha

0.91

Excellent reliability.

 

KMO Test

0.89

Suitable for factor analysis.

 

Factor Analysis

Four factors extracted:

• Affordability
• Trust
• Convenience
• Alternative Medicine

Total Variance Explained

72%

 

Chi-Square Test

Relationship:

Disease Type × Medicine Preference

χ² = 31.45

p < 0.001

Significant.

 

ANOVA

Customer Satisfaction

Source	F
Medicine Type	8.34

p=0.001

Significant.

 

Correlation

Variables	r
Price–Satisfaction	0.71
Trust–Brand Preference	0.82
Home Delivery–Satisfaction	0.66

 

Multiple Regression

Dependent Variable

Customer Satisfaction

R²

0.69

Predictors

• Price
• Trust
• Home Delivery
• Availability

All significant.

 

Structural Equation Model

Good Fit

CFI

0.95

RMSEA

0.05

 

11. Why Serious Patients Continue Using Branded Medicines

Ulcerative Colitis

Patients often continue prescribed mesalamine (5-ASA), immunomodulators, corticosteroids, or biologics because consistency is critical for maintaining remission. Changing formulations without medical advice may increase the risk of relapse.

Diabetes

Insulin and other glucose-lowering medicines require precise dosing, proper storage, and regular monitoring. Switching products based only on lower price can be unsafe without physician guidance.

Thyroid Disorders

Levothyroxine treatment should generally remain consistent. If a formulation is changed, clinicians commonly recommend follow-up thyroid function testing (e.g., TSH) after an appropriate interval.

Other Conditions

Extra caution is warranted with:

• Epilepsy
• Organ transplantation
• Anticoagulation therapy
• Biologic medicines
• Narrow therapeutic index drugs

These medicines often require careful monitoring when switching manufacturers or formulations.

 

12. Role of Alternative Medicines

Alternative systems may provide:

• Better perceived wellbeing
• Holistic consultation
• Lifestyle advice
• Higher patient satisfaction

However, patient satisfaction alone does not establish clinical effectiveness. Chronic diseases such as diabetes, thyroid disorders, and ulcerative colitis should continue to be monitored using objective clinical measures and managed under qualified medical supervision.

 

13. Customer Benefits from DavaIndia

Potential advantages include:

• Lower medicine costs
• Increased access to generic medicines
• Doorstep delivery
• Online ordering and tracking
• Better availability for long-term therapies
• Potential savings for families with chronic medication needs
• Improved convenience for elderly and mobility-limited patients

 

14. Is DavaIndia Safe?

DavaIndia is best described as an online and retail pharmacy, not as a medicine.

Using such services may be appropriate when customers:

• Purchase from the official platform.
• Verify manufacturer, batch number, expiry date, and packaging.
• Use valid prescriptions for prescription-only medicines.
• Confirm substitutions with their prescribing doctor, particularly for thyroid medicines, insulin, biologics, transplant medicines, and ulcerative colitis therapy.
• Ensure cold-chain handling for temperature-sensitive medicines such as insulin and some biologics.

The safety of any medicine depends on its active ingredient, manufacturing quality, regulatory approval, storage, and correct clinical use—not on the pharmacy through which it is purchased.

 

15. Regulatory Bodies Ensuring Generic Medicine Quality in India

Key regulatory authorities include:

• Central Drugs Standard Control Organization (CDSCO)
• Drug Controller General of India (DCGI)
• State Drug Control Departments
• Indian Pharmacopoeia Commission (quality standards)

Quality oversight includes:

• Good Manufacturing Practices (GMP)
• Manufacturing license inspections
• Batch testing
• Stability testing
• Pharmacovigilance
• Product recalls when necessary

 

16. Generic vs Biosimilar Medicines

Feature	Generic	Biosimilar
Small-molecule drug	Yes	No
Biologic	No	Yes
Identical active ingredient	Yes	Highly similar
Manufacturing complexity	Lower	Very high
Example	Levothyroxine tablets	Monoclonal antibodies

 

17. Findings

• Cost savings strongly influence customer satisfaction.
• Home delivery improves convenience and medication access.
• Physician recommendation remains the strongest predictor of medicine choice for chronic diseases.
• Trust in branded medicines remains higher among patients with serious illnesses.
• Generic medicines are widely accepted for many common conditions when prescribed appropriately.
• Alternative medicines are often used as complementary therapies rather than replacements.

 

18. Suggestions

• Improve public awareness of generic medicines.
• Strengthen pharmacist counseling.
• Enhance digital prescription verification.
• Increase transparency regarding manufacturers.
• Encourage physicians to discuss appropriate generic substitutions.
• Improve pharmacovigilance and patient education.

 

19. Conclusion

Online pharmacy platforms such as DavaIndia have contributed to improving medicine accessibility, affordability, and convenience for many patients. Generic medicines can provide clinically appropriate and cost-effective treatment when they are approved by regulators, manufactured under required quality standards, and prescribed appropriately. Nevertheless, patients with chronic or high-risk conditions—including ulcerative colitis, diabetes, thyroid disorders, transplant recipients, and those using biologics or narrow therapeutic index medicines—should not change medicines or formulations without consulting their treating physician. The optimal healthcare model combines affordable access, regulatory oversight, informed clinical decision-making, and patient-centered pharmaceutical care.

References

1. Central Drugs Standard Control Organization. (2024). Guidance documents for drugs and cosmetics regulation. Government of India.
2. Department of Pharmaceuticals. (2023). Pradhan Mantri Bhartiya Janaushadhi Pariyojana annual report. Government of India.
3. Indian Pharmacopoeia Commission. (2022). Indian Pharmacopoeia.
4. World Health Organization. (2023). WHO guideline on quality assurance of pharmaceutical products.
5. World Health Organization. (2023). The world medicines situation.
6. Organisation for Economic Co-operation and Development. (2023). Health at a Glance.
7. National Health Authority. (2024). Digital Health Mission Report.
8. National Pharmaceutical Pricing Authority. (2024). Annual report.
9. Pharmaceuticals Export Promotion Council of India. (2024). Indian pharmaceutical industry report.
10. Food and Drug Administration. (2023). Generic drugs: Questions and answers.
11. European Medicines Agency. (2023). Biosimilars in the European Union.
12. International Pharmaceutical Federation. (2022). Community pharmacy at a glance.
13. Kotler, P., & Keller, K. L. (2022). Marketing Management (16th ed.). Pearson.
14. Hair, J. F., Black, W. C., Babin, B. J., & Anderson, R. E. (2022). Multivariate Data Analysis (9th ed.). Cengage Learning.
15. Malhotra, N. K. (2021). Marketing Research: An Applied Orientation (8th ed.). Pearson.
16. Sekaran, U., & Bougie, R. (2020). Research Methods for Business (8th ed.). Wiley.
17. Creswell, J. W., & Creswell, J. D. (2023). Research Design (6th ed.). Sage.
18. Field, A. (2022). Discovering Statistics Using IBM SPSS Statistics (6th ed.). Sage.
19. Kothari, C. R., & Garg, G. (2021). Research Methodology: Methods and Techniques (4th ed.). New Age International.
20. Gupta, S. (2022). Healthcare Marketing in India. McGraw-Hill.

 

Teaching Notes

Case Title

DavaIndia's Role in Online Healthcare Services and Generic Medicines

 

Learning Objectives

After studying this case, students should be able to:

• Understand the Indian online pharmacy ecosystem.
• Compare branded and generic medicines.
• Analyze customer satisfaction in digital healthcare.
• Evaluate affordability versus trust in medicine selection.
• Explain why patients with chronic diseases often continue branded medicines.
• Understand regulatory oversight for medicine quality.
• Interpret statistical findings from healthcare research.
• Apply marketing concepts such as trust, perceived quality, and customer value to healthcare services.

 

Target Audience

• MBA
• BBA
• MHA (Master of Hospital Administration)
• M.Pharm
• B.Pharm
• Public Health
• Healthcare Management
• Pharmacy Practice
• Medical Administration

 

Suggested Class Duration

• Lecture: 90 minutes
• Case Discussion: 45 minutes
• Statistical Interpretation: 60 minutes
• Presentation: 30 minutes

 

Discussion Questions

1. Why do patients continue using branded medicines despite lower-cost generics?
2. How does affordability influence customer satisfaction?
3. What role does physician trust play in medicine selection?
4. How do online pharmacies improve medicine access?
5. What precautions should patients take when purchasing medicines online?
6. Can patient satisfaction alone demonstrate treatment effectiveness?
7. How should policymakers encourage appropriate use of quality-assured generic medicines?

 

Classroom Activities

• Compare prices of branded and generic medicines (using publicly available data).
• Debate: "Brand Loyalty versus Generic Medicines."
• Analyze hypothetical patient scenarios involving medicine substitution.
• Interpret regression and ANOVA outputs from the case dataset.
• Design a customer awareness campaign for safe online medicine purchasing.

 

Expected Learning Outcomes

Students will be able to:

• Interpret healthcare consumer behavior.
• Analyze patient satisfaction data.
• Evaluate digital pharmacy business models.
• Apply statistical tools in healthcare research.
• Develop evidence-based managerial recommendations.

 

Appendix

Appendix A

Questionnaire

• Demographic Profile
• Disease Category
• Medicine Purchased
• Online Pharmacy Usage
• Customer Satisfaction Scale
• Trust Scale
• Affordability Scale
• Alternative Medicine Usage
• Repurchase Intention
• Doctor Recommendation

 

Appendix B

Hypothetical Dataset

500 Respondents

Variables

• Age
• Gender
• Income
• Disease
• Medicine Type
• Generic Purchase
• Branded Purchase
• Satisfaction Score
• Trust Score
• Delivery Satisfaction

 

Appendix C

Reliability Analysis

• Cronbach's Alpha
• Composite Reliability
• Average Variance Extracted (AVE)

 

Appendix D

Factor Analysis Output

• KMO
• Bartlett's Test
• Rotated Component Matrix
• Communalities
• Total Variance Explained

 

Appendix E

Statistical Analysis

• Descriptive Statistics
• Correlation Matrix
• Chi-square Test
• Independent t-test
• ANOVA
• Multiple Regression
• Structural Equation Modeling (SEM)

 

Appendix F

Case Study

Illustrative Case: A patient with ulcerative colitis has maintained remission using a physician-prescribed treatment for several years. When offered a lower-cost generic alternative through an online pharmacy, the patient consults the treating gastroenterologist before making any change. After reviewing the active ingredient, formulation, and clinical considerations, the physician advises whether substitution is appropriate and recommends follow-up monitoring if needed. This case highlights the importance of medical supervision when considering medicine substitutions in chronic diseases.

 

Appendix G

Comparison Table

Parameter	Generic Medicine	Branded Medicine
Price	Lower	Higher
Active Ingredient	Same (approved equivalent)	Same
Manufacturer	Varies	Brand company
Marketing Cost	Lower	Higher
Availability	Increasing	Widely available
Patient Trust	Moderate to High	Often High
Doctor Preference	Depends on clinical situation	Common in chronic disease management

 

Appendix H

Managerial and Policy Recommendations

• Expand public awareness about quality-assured generic medicines.
• Strengthen pharmacist counseling and prescription verification.
• Promote digital prescription integration with online pharmacies.
• Increase transparency regarding manufacturers and quality standards.
• Enhance pharmacovigilance and adverse-event reporting.
• Encourage physician–pharmacist collaboration for appropriate generic substitution.
• Support evidence-based use of complementary therapies while maintaining continuity of essential treatment.